Median Technologies SA has appointed Oran Muduroglu as President of Median eyonis Inc., its U.S. subsidiary, to lead the U.S. launch and scale-up of the eyonis® LCS lung cancer screening software. Median eyonis Inc. is expanding U.S. commercial and clinical support teams and will pursue a phased national rollout, including distribution partnerships such as a non-exclusive agreement with Tempus AI to integrate eyonis® LCS into Tempus’ Pixel platform.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Median Technologies SA published the original content used to generate this news brief via Business Wire (Ref. ID: 20260218440005) on February 18, 2026, and is solely responsible for the information contained therein.